Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001209191-21-044168

Options or other derivatives

  • Director acquired 7,728 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Nayeem Sara M. Director 2021-06-29 Grant or award · Stock Options (Right to Buy) +7,728 7,728 D: show line 1 in the form
Loading xslF345X03/doc4.xml…